Approach to Erectile Dysfunction

Initial Evaluation

• The American College of Physicians recommends beginning with a comprehensive sexual, medical, and psychosocial history, followed by a focused physical examination and targeted laboratory testing to identify both organic causes and psychogenic factors 1
• The onset pattern of erectile dysfunction suggests psychogenic causes if sudden, while gradual onset indicates organic etiology, according to the British Medical Journal 2, 1
• The International Index of Erectile Function (IIEF) or Sexual Health Inventory for Men can be used to objectively quantify the severity of erectile dysfunction, as suggested by Praxis Medical Insights 1, 3
• Cardiovascular risk factors such as hypertension, atherosclerosis, hyperlipidemia, diabetes mellitus, smoking, and family history of vascular disease should be identified, as noted in The Journal of Urology 4, 1
• Neurological conditions like prior pelvic/perineal trauma or surgery, spinal cord injury, and neurologic disease should be assessed, according to The Journal of Urology 4
• The American Urological Association suggests evaluating endocrine disorders, including signs or symptoms of hypogonadism and obesity 1
• A medication review should be conducted to identify potential contributors to erectile dysfunction, such as antihypertensives, antidepressants, tranquilizers, and recreational drugs, as recommended by the British Medical Journal 2, 1
• The psychosocial assessment must evaluate relationship factors, including partner's sexual function, relationship quality, and presence of major life events, according to the British Medical Journal 2, 1
• Psychiatric conditions like depression, generalized anxiety, alcoholism, and body dysmorphic disorder should be considered, as suggested by the British Medical Journal 2

Physical Examination and Laboratory Testing

• The American Urological Association recommends performing a focused examination, including vital signs, genital examination, and assessment of secondary sexual characteristics, as noted in The Journal of Urology 4, 1
• Essential laboratory tests for all patients include morning serum total testosterone, fasting glucose or HbA1c, and lipid profile, as suggested by Praxis Medical Insights 1, 3
• Additional testing, such as free testosterone or androgen index, prostate-specific antigen, and digital rectal examination, may be necessary in select patients, according to the British Medical Journal 2, 3

Treatment Framework

• The European Association of Urology suggests that erectile dysfunction is a sentinel marker for cardiovascular disease and warrants comprehensive cardiovascular risk assessment, as noted in Praxis Medical Insights 1, 3
• The treatment algorithm should include addressing modifiable factors, such as lifestyle modifications and optimization of comorbid conditions, as recommended by the British Medical Journal 2
• Oral phosphodiesterase-5 inhibitors are the first-line treatment for most patients with erectile dysfunction, according to The Journal of Urology 4
• The American Urological Association recommends considering second-line therapy, including intracavernosal alprostadil injection and vacuum constriction devices, for patients who fail or cannot tolerate phosphodiesterase-5 inhibitors, as noted in The Journal of Urology 4
• Psychosexual counseling should be combined with pharmacotherapy for optimal outcomes, as most erectile dysfunction is multifactorial, according to the British Medical Journal 2
• Specialist referral to urology or andrology may be necessary for certain patients, such as young patients with lifelong erectile dysfunction or those with a history of pelvic trauma, as suggested by the British Medical Journal 2, 4
• Testosterone replacement therapy should only be initiated in men with documented hypogonadism, as recommended by Praxis Medical Insights 3

Management of Erectile Dysfunction in Young Men with Alcohol Abuse

Assessment

History

• Sudden onset of erectile dysfunction suggests a psychogenic etiology, whereas a gradual onset points toward an organic cause. 5
• The presence of morning or nocturnal erections strongly indicates a psychogenic component. 5
• Erectile difficulty that occurs only with a specific partner (e.g., the girlfriend) is indicative of relationship‑related performance anxiety. 6
• Heavy alcohol consumption is a direct risk factor for organic erectile dysfunction and should be quantified during history taking. 5
• Screening for psychiatric comorbidities such as depression, generalized anxiety, and alcohol use disorder is essential before initiating ED treatment. 7

Physical Examination

• Measure blood pressure as part of the cardiovascular assessment in men with erectile dysfunction. 5
• Perform a genital examination to assess testicular size (for hypogonadism), look for penile plaques (Peyronie’s disease), and evaluate foreskin retractability. 5
• Evaluate secondary sexual characteristics (e.g., body hair distribution, muscle mass) to identify possible hypogonadism. 6

Laboratory Testing

• Obtain a morning serum total testosterone level in every man presenting with erectile dysfunction. 6
• If total testosterone is low, further endocrine work‑up should include luteinizing hormone, prolactin, and free testosterone or an androgen index. 5

Treatment

Primary Intervention – Alcohol Cessation

• Complete abstinence from alcohol is the most critical first‑step intervention because heavy alcohol use is a direct cause of erectile dysfunction. 5

Lifestyle Modifications

• Counsel the patient on total alcohol abstinence and address other modifiable cardiovascular risk factors as identified (e.g., hypertension, dyslipidemia). 5

Psychosexual Counseling

• Refer the patient to a mental‑health professional or certified sex therapist as first‑line therapy, given the high likelihood of a psychogenic component in young men. 6
• Psychosexual therapy achieves successful outcomes in 50 %–80 % of patients with erectile dysfunction. 5
• The American Urological Association recommends mental‑health referral to improve treatment adherence and reduce performance anxiety. 6

Pharmacotherapy

• If counseling alone is insufficient, initiate an oral phosphodiesterase‑5 (PDE5) inhibitor (e.g., sildenafil, tadalafil, vardenafil, avanafil); these agents enable successful intercourse in 60 %–65 % of men and have demonstrated safety in > 3 700 patients. 5
• Combining PDE5 inhibitor therapy with psychosexual counseling yields optimal outcomes compared with either modality alone. 5

Treatment Selection Framework

• Final therapeutic choice should be individualized after providing the patient with unbiased information on all options, their benefits, and risks, respecting patient preferences. 5

Cardiovascular Risk Assessment

• Erectile dysfunction in a man as young as 26 should be considered a sentinel marker for underlying cardiovascular disease and warrants appropriate risk stratification. 6

Critical Pitfalls to Avoid

• Do not initiate erectile‑dysfunction treatment before addressing alcohol dependence; the psychiatric issue must be managed first. 7
• Do not assume a purely psychogenic cause without laboratory evaluation; obtain testosterone, glucose, and lipid studies in every patient. 6
• Do not prescribe testosterone replacement unless hypogonadism is documented (total testosterone < 300 ng/dL with compatible symptoms). 6
• Do not overlook the partner’s role; involve the girlfriend in counseling and treatment planning when appropriate. 5